Reckitt Benckiser Pharmaceuticals ( Pharmaceutical Import Profile — South Africa (DGFT 2022–2026)

Name: Reckitt Benckiser Pharmaceuticals ( Pharmaceutical Import Records from India — 3 Products, $22.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Reckitt Benckiser Pharmaceuticals ( — Pharmaceutical Importer Profile (2026) | 3 Products, $22.3M Trade | TransData Nexus

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Disprin	Brand Names & OTC Products	$10.5M	534	63.9%	1
2	Aspirin	Analgesics & Antipyretics	$5.9M	353	8.2%	1
3	Salicylic	Combination Drugs	$5.9M	350	18.0%	1

Reckitt Benckiser Pharmaceuticals ( imports 3 pharmaceutical products across 3 categories into South Africa totaling $22.3M. The company is the #1 buyer for 3 products: Disprin, Aspirin, Salicylic.

Reckitt Benckiser Pharmaceuticals ( — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Reckitt Benckiser Pharmaceuticals (Pty) Ltd, a subsidiary of the British multinational consumer goods company Reckitt Benckiser Group plc, operates as a pharmaceutical importer and distributor in South Africa. The company is headquartered at 8 Jet Park Road, Elandsfontein, Gauteng, South Africa, 1406, with its commercial site located at Ground Floor, North Wing, Allandale Building, 39 Magwa Crescent, Waterfall, Gauteng, South Africa, 2090.

Reckitt Benckiser Pharmaceuticals specializes in the importation and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. In South Africa, the company plays a significant role in the pharmaceutical supply chain, ensuring the availability of various health products to meet the needs of the local market.

2Distribution Network

Reckitt Benckiser Pharmaceuticals maintains a robust distribution network within South Africa, with its primary warehouse located at 8 Jet Park Road, Elandsfontein, Gauteng, South Africa, 1406. This strategic location facilitates efficient logistics and timely delivery of pharmaceutical products across the country. While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, the company's established presence in South Africa indicates a well-organized distribution system capable of serving both urban and rural regions.

3Industry Role

In South Africa's pharmaceutical supply chain, Reckitt Benckiser Pharmaceuticals functions primarily as a pharmaceutical importer and distributor. The company imports finished pharmaceutical formulations from various countries, including India, and distributes them to local retailers, hospitals, and other healthcare providers. By focusing on the importation and distribution of finished products, Reckitt Benckiser Pharmaceuticals ensures a steady supply of essential medications to the South African market, contributing to the overall health infrastructure of the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Reckitt Benckiser Pharmaceuticals (

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Reckitt Benckiser Pharmaceuticals demonstrates a high level of sourcing concentration, importing a total of $22.3 million USD worth of finished pharmaceutical formulations from India across 1,237 shipments. The top three products imported are Disprin ($10.5 million, 63.9% share), Aspirin ($5.9 million, 8.2% share), and Salicylic ($5.9 million, 18.0% share). This concentration indicates a strategic choice to source key products from a single supplier, potentially leveraging cost efficiencies and ensuring consistent product quality.

The shipment data reveals a stable and ongoing relationship with Indian suppliers, as evidenced by the consistent importation of these products over the years. This stability suggests a reliable supply chain and a strong partnership between Reckitt Benckiser Pharmaceuticals and its Indian suppliers.

2Supply Chain Resilience

Reckitt Benckiser Pharmaceuticals' supply chain resilience is supported by its focused sourcing strategy from India, particularly for key products like Disprin, Aspirin, and Salicylic. While the company imports finished pharmaceutical formulations, specific details about backup suppliers and formulation diversity are not publicly disclosed. The company's established presence in South Africa and its strategic sourcing decisions indicate a well-managed supply chain capable of adapting to market demands and potential disruptions.

Importing Pharmaceuticals into South Africa — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for South Africa

1Regulatory Authority & Framework

In South Africa, the South African Health Products Regulatory Authority (SAHPRA) is responsible for regulating health products, including pharmaceuticals. SAHPRA ensures that all health products meet safety, efficacy, and quality standards before they are imported and marketed in the country. The key legislation governing pharmaceutical imports includes the Medicines and Related Substances Act, which outlines the requirements for the registration, importation, and distribution of medicines.

The marketing authorization pathway for Indian generics involves obtaining approval from SAHPRA, which includes submitting comprehensive data on the product's quality, safety, and efficacy. This process ensures that imported generics meet the necessary standards for the South African market.

2Import Licensing & GMP

Import licensing requirements in South Africa stipulate that all pharmaceutical products must be registered with SAHPRA before importation. Manufacturers must provide evidence of Good Manufacturing Practice (GMP) compliance, typically through certificates such as EU GMP, WHO GMP, or PIC/S. These certifications demonstrate adherence to internationally recognized manufacturing standards.

Wholesale distribution authorization is also required, ensuring that distributors operate in compliance with regulatory standards and maintain the integrity of the pharmaceutical supply chain.

Reckitt Benckiser Pharmaceuticals ( — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Reckitt Benckiser Pharmaceuticals' product category focus on Brand Names & OTC Products (47.2%), Analgesics & Antipyretics (26.6%), and Combination Drugs (26.2%) reflects a strategic alignment with market demand for over-the-counter pain relief and combination therapies. The high import value of Disprin, Aspirin, and Salicylic indicates a strong market presence and consumer preference for these products. This focus suggests that Reckitt Benckiser Pharmaceuticals is well-positioned to meet the analgesic needs of the South African market.

2Sourcing Profile

Reckitt Benckiser Pharmaceuticals' sourcing strategy emphasizes importing finished pharmaceutical formulations from India, particularly in the analgesics and antipyretics category. This approach leverages India's established pharmaceutical manufacturing capabilities and cost efficiencies. The company's focus on specific products like Disprin, Aspirin, and Salicylic indicates a targeted procurement strategy aimed at meeting the analgesic needs of the South African market.

3Market Positioning

Based on its product mix, Reckitt Benckiser Pharmaceuticals serves the retail pharmacy segment in South Africa, providing over-the-counter analgesic products to consumers. The company's focus on widely recognized brands and its significant import value in the analgesics category position it as a key player in the retail pharmacy market.

Seller's Guide — How to Become a Supplier to Reckitt Benckiser Pharmaceuticals (

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the South African market by partnering with Reckitt Benckiser Pharmaceuticals. The company's concentrated sourcing pattern indicates a potential openness to diversifying its supplier base, provided that new suppliers can meet the required quality standards and regulatory compliance. Gaps in Reckitt Benckiser Pharmaceuticals' current sourcing may include a need for additional product offerings or alternative formulations to cater to evolving market demands.

2Requirements & Qualifications

Indian exporters seeking to supply Reckitt Benckiser Pharmaceuticals and the South African market must obtain GMP certifications recognized by SAHPRA, such as EU GMP, WHO GMP, or PIC/S. Additionally, they must ensure that their products are registered with SAHPRA and comply with all labeling, packaging, and serialization requirements. Maintaining high-quality standards and adhering to regulatory guidelines are essential for successful market entry.

3How to Approach

Frequently Asked Questions — Reckitt Benckiser Pharmaceuticals (

What products does Reckitt Benckiser Pharmaceuticals ( import from India?

Reckitt Benckiser Pharmaceuticals ( imports 3 pharmaceutical products across 3 categories. Top imports: Disprin ($10.5M), Aspirin ($5.9M), Salicylic ($5.9M).

What is Reckitt Benckiser Pharmaceuticals ('s total pharmaceutical import value?

Reckitt Benckiser Pharmaceuticals ('s total pharmaceutical import value from India is $22.3M, based on 1,237 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Reckitt Benckiser Pharmaceuticals ( focus on?

Reckitt Benckiser Pharmaceuticals ( imports across 3 categories. The largest: Brand Names & OTC Products (47.2%), Analgesics & Antipyretics (26.6%), Combination Drugs (26.2%).

Get Full Reckitt Benckiser Pharmaceuticals ( Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Reckitt Benckiser Pharmaceuticals (

Reckitt Benckiser Pharmaceuticals ( — Import Portfolio & Supplier Network

What Products Does Reckitt Benckiser Pharmaceuticals ( Import?

Top Products by Import Value

Reckitt Benckiser Pharmaceuticals ( Therapeutic Categories — 3 Specializations